Guideline for Adherence and Diabetes Control in CoMorbid Conditions in a Tertiary Hospital in Malaysia

Mohammad Zahid Iqbal, Amer Hayat Khan, Syed Azhar Syed Sulaiman, Muhammad Shahid Iqbal, Zahid Hussain

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: To evaluate doctors’ adherence to Malaysian Clinical Practice Guideline (CPG) 2009 inestablished diabetic patients with hypertension, dyslipidemia, renal diseases, obesity, and also toassess factors associated with guideline adherence and diabetes mellitus control in Pulau PinangHospital, Malaysia.Method: Prescriptions written by 24 doctors for 480 established diabetic patients with hypertension,dyslipidemia, renal diseases and obesity (20 patients per doctor) were noted. The control of the diseaseand CPG adherence were noted from the selected prescriptions.Results: Three hundred and forty nine (72.7 %) patients received guideline-compliantpharmacotherapy. CPG adherence had statistically non-significant association (p < 0.301) withhypertension, hypertension with dyslipidemia (p < 0.078), dyslipidemia (p < 0.061), renal diseases (p <0.544) and obesity (p < 0.073). Two hundred and ninety nine (62.3 %) patients were at goal bloodglucose level. Diabetes Mellitus (DM) control had statistically significant association (Ф = 0.583, p <0.001) with guideline compliance and statistically non-significant association (p < 0.066) with comorbidities and also non-significant association (p < 0.300) with therapies.Conclusion: Prescribing practices were fairly compliant with guidelines. Doctors poorly adhered toguidelines in diabetic patients with hypertension, dislipidemia, renal diseases and obesity. Significantlybetter diabetic control was seen in patients who were on monotherapy and guidelines-adherent therapy. 
Original languageEnglish
Pages (from-to)1739-1744
Number of pages6
JournalTropical Journal of Pharmaceutical Research
Volume13
Issue number10
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Guideline Adherence
Malaysia
Tertiary Care Centers
Dyslipidemias
Renal Hypertension
Obesity
Practice Guidelines
Guidelines
Prescriptions
Diabetes Mellitus
Compliance
Comorbidity
Hypertension
Kidney
Therapeutics

Cite this

Iqbal, Mohammad Zahid ; Khan, Amer Hayat ; Syed Sulaiman, Syed Azhar ; Iqbal, Muhammad Shahid ; Hussain, Zahid. / Guideline for Adherence and Diabetes Control in CoMorbid Conditions in a Tertiary Hospital in Malaysia. In: Tropical Journal of Pharmaceutical Research. 2014 ; Vol. 13, No. 10. pp. 1739-1744.
@article{26cbb369ae724653af773ac922d6009c,
title = "Guideline for Adherence and Diabetes Control in CoMorbid Conditions in a Tertiary Hospital in Malaysia",
abstract = "Purpose: To evaluate doctors’ adherence to Malaysian Clinical Practice Guideline (CPG) 2009 inestablished diabetic patients with hypertension, dyslipidemia, renal diseases, obesity, and also toassess factors associated with guideline adherence and diabetes mellitus control in Pulau PinangHospital, Malaysia.Method: Prescriptions written by 24 doctors for 480 established diabetic patients with hypertension,dyslipidemia, renal diseases and obesity (20 patients per doctor) were noted. The control of the diseaseand CPG adherence were noted from the selected prescriptions.Results: Three hundred and forty nine (72.7 {\%}) patients received guideline-compliantpharmacotherapy. CPG adherence had statistically non-significant association (p < 0.301) withhypertension, hypertension with dyslipidemia (p < 0.078), dyslipidemia (p < 0.061), renal diseases (p <0.544) and obesity (p < 0.073). Two hundred and ninety nine (62.3 {\%}) patients were at goal bloodglucose level. Diabetes Mellitus (DM) control had statistically significant association (Ф = 0.583, p <0.001) with guideline compliance and statistically non-significant association (p < 0.066) with comorbidities and also non-significant association (p < 0.300) with therapies.Conclusion: Prescribing practices were fairly compliant with guidelines. Doctors poorly adhered toguidelines in diabetic patients with hypertension, dislipidemia, renal diseases and obesity. Significantlybetter diabetic control was seen in patients who were on monotherapy and guidelines-adherent therapy. ",
author = "Iqbal, {Mohammad Zahid} and Khan, {Amer Hayat} and {Syed Sulaiman}, {Syed Azhar} and Iqbal, {Muhammad Shahid} and Zahid Hussain",
year = "2014",
doi = "10.4314/tjpr.v13i10.25",
language = "English",
volume = "13",
pages = "1739--1744",
journal = "Tropical Journal of Pharmaceutical Research",
issn = "1596-5996",
publisher = "Pharmacotherapy Group",
number = "10",

}

Guideline for Adherence and Diabetes Control in CoMorbid Conditions in a Tertiary Hospital in Malaysia. / Iqbal, Mohammad Zahid; Khan, Amer Hayat; Syed Sulaiman, Syed Azhar; Iqbal, Muhammad Shahid; Hussain, Zahid.

In: Tropical Journal of Pharmaceutical Research, Vol. 13, No. 10, 2014, p. 1739-1744.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Guideline for Adherence and Diabetes Control in CoMorbid Conditions in a Tertiary Hospital in Malaysia

AU - Iqbal, Mohammad Zahid

AU - Khan, Amer Hayat

AU - Syed Sulaiman, Syed Azhar

AU - Iqbal, Muhammad Shahid

AU - Hussain, Zahid

PY - 2014

Y1 - 2014

N2 - Purpose: To evaluate doctors’ adherence to Malaysian Clinical Practice Guideline (CPG) 2009 inestablished diabetic patients with hypertension, dyslipidemia, renal diseases, obesity, and also toassess factors associated with guideline adherence and diabetes mellitus control in Pulau PinangHospital, Malaysia.Method: Prescriptions written by 24 doctors for 480 established diabetic patients with hypertension,dyslipidemia, renal diseases and obesity (20 patients per doctor) were noted. The control of the diseaseand CPG adherence were noted from the selected prescriptions.Results: Three hundred and forty nine (72.7 %) patients received guideline-compliantpharmacotherapy. CPG adherence had statistically non-significant association (p < 0.301) withhypertension, hypertension with dyslipidemia (p < 0.078), dyslipidemia (p < 0.061), renal diseases (p <0.544) and obesity (p < 0.073). Two hundred and ninety nine (62.3 %) patients were at goal bloodglucose level. Diabetes Mellitus (DM) control had statistically significant association (Ф = 0.583, p <0.001) with guideline compliance and statistically non-significant association (p < 0.066) with comorbidities and also non-significant association (p < 0.300) with therapies.Conclusion: Prescribing practices were fairly compliant with guidelines. Doctors poorly adhered toguidelines in diabetic patients with hypertension, dislipidemia, renal diseases and obesity. Significantlybetter diabetic control was seen in patients who were on monotherapy and guidelines-adherent therapy. 

AB - Purpose: To evaluate doctors’ adherence to Malaysian Clinical Practice Guideline (CPG) 2009 inestablished diabetic patients with hypertension, dyslipidemia, renal diseases, obesity, and also toassess factors associated with guideline adherence and diabetes mellitus control in Pulau PinangHospital, Malaysia.Method: Prescriptions written by 24 doctors for 480 established diabetic patients with hypertension,dyslipidemia, renal diseases and obesity (20 patients per doctor) were noted. The control of the diseaseand CPG adherence were noted from the selected prescriptions.Results: Three hundred and forty nine (72.7 %) patients received guideline-compliantpharmacotherapy. CPG adherence had statistically non-significant association (p < 0.301) withhypertension, hypertension with dyslipidemia (p < 0.078), dyslipidemia (p < 0.061), renal diseases (p <0.544) and obesity (p < 0.073). Two hundred and ninety nine (62.3 %) patients were at goal bloodglucose level. Diabetes Mellitus (DM) control had statistically significant association (Ф = 0.583, p <0.001) with guideline compliance and statistically non-significant association (p < 0.066) with comorbidities and also non-significant association (p < 0.300) with therapies.Conclusion: Prescribing practices were fairly compliant with guidelines. Doctors poorly adhered toguidelines in diabetic patients with hypertension, dislipidemia, renal diseases and obesity. Significantlybetter diabetic control was seen in patients who were on monotherapy and guidelines-adherent therapy. 

UR - https://www.tjpr.org/home/achieve.php?vol=13&no=10&yr=2014

U2 - 10.4314/tjpr.v13i10.25

DO - 10.4314/tjpr.v13i10.25

M3 - Article

VL - 13

SP - 1739

EP - 1744

JO - Tropical Journal of Pharmaceutical Research

JF - Tropical Journal of Pharmaceutical Research

SN - 1596-5996

IS - 10

ER -